Mađarska - mađarski - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

pharos pharmaceutical oriented services ltd. - entekavirt -

Mađarska - mađarski - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

pharos pharmaceutical oriented services ltd. - entekavirt -

Mađarska - mađarski - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

pharos pharmaceutical oriented services ltd. - entekavirt -

Mađarska - mađarski - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

hermes arzneimittel gmbh - int-rac-alfa-tokoferol -

Mađarska - mađarski - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

hermes arzneimittel gmbh - int-rac-alfa-tokoferol -

Mađarska - mađarski - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

hermes arzneimittel gmbh -

Mađarska - mađarski - NÉBIH (Nemzeti Élelmiszerlánc-biztonsági Hivatal)

giantel b.v. - levamizol - por belsoleges oldathoz - galamb (dísz galamb)

Europska Unija - mađarski - EMA (European Medicines Agency)

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kalcium homeosztázis - a csontritkulás kezelése a posztmenopauzás nőknél a törések kockázatának fokozódásával.

Europska Unija - mađarski - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil-hidroklorid - colorectalis daganatok - daganatellenes szerek - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Europska Unija - mađarski - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.